Literature DB >> 15375595

Role of Us3 gene of herpes simplex virus type 1 for resistance to interferon.

Ahmad Piroozmand1, A Hajime Koyama, Yoshiko Shimada, Mikako Fujita, Tsutomu Arakawa, Akio Adachi.   

Abstract

The sensitivity of a Us3-deletion mutant virus of herpes simplex virus type 1 (HSV-1) to consensus interferon (IFN) was compared with that of parental wild-type (wt) and the repaired viruses. Although one-step growth of the Us3-deficient virus in the IFN-treated HEp-2 cells was not markedly affected at a high multiplicity of infection (MOI), both the progeny virus yield and cytopathic effect were suppressed in a significantly higher degree in the mutant virus-infected cells than those in wt or the repaired virus-infected cells. This enhanced IFN-sensitivity of the mutant virus was more clearly demonstrated by the infection at a low MOI. In addition, both the size and number of plaques of the Us3-deficient virus in Vero cells were remarkably reduced with increasing concentrations of IFN, compared to those of wt or the repaired virus. These results indicate that the deletion of Us3 gene makes HSV-1 more sensitive to IFN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15375595

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  13 in total

Review 1.  Viral serine/threonine protein kinases.

Authors:  Thary Jacob; Céline Van den Broeke; Herman W Favoreel
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

2.  Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase.

Authors:  Amie J Eisfeld; Stephanie E Turse; Sara A Jackson; Edwina C Lerner; Paul R Kinchington
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  The Us3 Protein of Herpes Simplex Virus 1 Inhibits T Cell Signaling by Confining Linker for Activation of T Cells (LAT) Activation via TRAF6 Protein.

Authors:  Yin Yang; Songfang Wu; Yu Wang; Shuang Pan; Bei Lan; Yaohui Liu; Liming Zhang; Qianli Leng; Da Chen; Cuizhu Zhang; Bin He; Youjia Cao
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

4.  Equid Herpesvirus 1 Targets the Sensitization and Induction Steps To Inhibit the Type I Interferon Response in Equine Endothelial Cells.

Authors:  Fatai S Oladunni; Sanjay Sarkar; Stephanie Reedy; Udeni B R Balasuriya; David W Horohov; Thomas M Chambers
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

5.  Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production.

Authors:  Shuai Wang; Kezhen Wang; Rongtuan Lin; Chunfu Zheng
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

6.  Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-κB activation.

Authors:  Kezhen Wang; Liwen Ni; Shuai Wang; Chunfu Zheng
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

7.  Neurons versus herpes simplex virus: the innate immune interactions that contribute to a host-pathogen standoff.

Authors:  Pamela C Rosato; David A Leib
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

8.  Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity.

Authors:  Heather E Eaton; Holly A Saffran; Frederick W Wu; Kevin Quach; James R Smiley
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

Review 9.  Recognition of herpes simplex viruses: toll-like receptors and beyond.

Authors:  Yijie Ma; Bin He
Journal:  J Mol Biol       Date:  2013-11-19       Impact factor: 5.469

10.  The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions.

Authors:  Svetlana Gershburg; Joshua Geltz; Karin E Peterson; William P Halford; Edward Gershburg
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.